Rx only · Injection, Solution · Intravenous
Rocuronium
Rocuronium Bromide
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.394
Latest avg · Apr 22, 2026
+0%
Since Mar 18, 2026
3
Active US suppliers
75%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
691
Rx · 2026 Q1
3.5K
Units dispensed
-39%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Piramal Critical Care Inc | unknown | 2 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 1 | SUPPLYING |
| Medical Purchasing Solutions, LLC | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Feb 15, 2023SHORTAGEDrug shortage: Rocuronium Bromide Injection (Piramal Critical Care Inc.)
Rocuronium Bromide Injection — reported in shortage by Piramal Critical Care Inc.. Therapeutic category: Anesthesia.
Pill